DK140834C - - Google Patents

Info

Publication number
DK140834C
DK140834C DK457475A DK457475A DK140834C DK 140834 C DK140834 C DK 140834C DK 457475 A DK457475 A DK 457475A DK 457475 A DK457475 A DK 457475A DK 140834 C DK140834 C DK 140834C
Authority
DK
Denmark
Application number
DK457475A
Other languages
Danish (da)
Other versions
DK457475A (enEXAMPLES
DK140834B (da
Inventor
U Fischer
E Lorch
Original Assignee
Hoffmann F. La Roche & Co Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann F. La Roche & Co Ag filed Critical Hoffmann F. La Roche & Co Ag
Publication of DK457475A publication Critical patent/DK457475A/da
Publication of DK140834B publication Critical patent/DK140834B/da
Application granted granted Critical
Publication of DK140834C publication Critical patent/DK140834C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK457475AA 1974-10-11 1975-10-10 Analogifremgangsmåde til fremstilling af biguanidsalte. DK140834B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1369774A CH602612A5 (enEXAMPLES) 1974-10-11 1974-10-11

Publications (3)

Publication Number Publication Date
DK457475A DK457475A (enEXAMPLES) 1976-04-12
DK140834B DK140834B (da) 1979-11-26
DK140834C true DK140834C (enEXAMPLES) 1980-04-28

Family

ID=4394567

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457475AA DK140834B (da) 1974-10-11 1975-10-10 Analogifremgangsmåde til fremstilling af biguanidsalte.

Country Status (26)

Country Link
US (1) US4028402A (enEXAMPLES)
JP (1) JPS51125718A (enEXAMPLES)
AR (1) AR209457A1 (enEXAMPLES)
AT (1) AT343676B (enEXAMPLES)
BE (1) BE834369A (enEXAMPLES)
BR (1) BR7506595A (enEXAMPLES)
CA (1) CA1053258A (enEXAMPLES)
CH (1) CH602612A5 (enEXAMPLES)
CU (1) CU34371A (enEXAMPLES)
DD (1) DD123322A5 (enEXAMPLES)
DE (1) DE2542598A1 (enEXAMPLES)
DK (1) DK140834B (enEXAMPLES)
ES (1) ES441673A1 (enEXAMPLES)
FI (1) FI752626A7 (enEXAMPLES)
FR (1) FR2287221A1 (enEXAMPLES)
GB (1) GB1473256A (enEXAMPLES)
IE (1) IE41807B1 (enEXAMPLES)
IL (1) IL48116A (enEXAMPLES)
LU (1) LU73557A1 (enEXAMPLES)
NL (1) NL7511890A (enEXAMPLES)
NO (1) NO753447L (enEXAMPLES)
PH (1) PH12279A (enEXAMPLES)
PL (1) PL95259B1 (enEXAMPLES)
SE (1) SE7511357L (enEXAMPLES)
SU (1) SU572200A3 (enEXAMPLES)
ZA (1) ZA755861B (enEXAMPLES)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401898A1 (fr) * 1977-09-05 1979-03-30 Aec Chim Organ Biolog Nouveau sel de l'acide patoique
DE19616486C5 (de) 1996-04-25 2016-06-30 Royalty Pharma Collection Trust Verfahren zur Senkung des Blutglukosespiegels in Säugern
US20020006899A1 (en) * 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
EP1004304A4 (en) 1996-12-24 2002-10-16 Sumitomo Pharma COMPOSITION CONTAINING ASCORBIC ACID
DE19823831A1 (de) * 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
DE19828114A1 (de) 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19828113A1 (de) 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19834591A1 (de) 1998-07-31 2000-02-03 Probiodrug Ges Fuer Arzneim Verfahren zur Steigerung des Blutglukosespiegels in Säugern
US20030176357A1 (en) * 1998-10-06 2003-09-18 Pospisilik Andrew J. Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
DE19926233C1 (de) 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
DE19940130A1 (de) * 1999-08-24 2001-03-01 Probiodrug Ges Fuer Arzneim Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
EP1228756A4 (en) 1999-10-06 2004-06-09 Kurokawa Kiyoshi ACTIVE AGENTS AGAINST CARBONYL STRESS
US20080076811A1 (en) * 2000-01-21 2008-03-27 Bork Balkan Combinations comprising depeptidypeptidase-iv inhibitors and antidiabetic agents
CN101690815A (zh) * 2000-03-31 2010-04-07 普罗西迪恩有限公司 二肽基肽酶iv酶活性抑制剂的新用途
FR2809310B1 (fr) 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
JP2005097117A (ja) * 2000-06-30 2005-04-14 Chugai Pharmaceut Co Ltd 糖尿病治療剤
AU2177302A (en) * 2000-10-27 2002-05-06 Probiodrug Ag Method for the treatment of neurological and neuropsychological disorders
US7132104B1 (en) 2000-10-27 2006-11-07 Probiodrug Ag Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
US6890905B2 (en) 2001-04-02 2005-05-10 Prosidion Limited Methods for improving islet signaling in diabetes mellitus and for its prevention
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
DE10150203A1 (de) 2001-10-12 2003-04-17 Probiodrug Ag Peptidylketone als Inhibitoren der DPIV
US7368421B2 (en) 2001-06-27 2008-05-06 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
EP1492525A2 (en) * 2001-08-16 2005-01-05 Probiodrug AG Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
DK1480961T3 (da) 2002-02-28 2007-05-07 Prosidion Ltd Glutaminylbaserede DPIV-inhibitorer
US20030232761A1 (en) * 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
US20040033051A1 (en) * 2002-08-16 2004-02-19 Ip Kiril Kun Wan Method and system for producing and displaying visual presentations which inhibit off-screen duplication
US20040058876A1 (en) * 2002-09-18 2004-03-25 Torsten Hoffmann Secondary binding site of dipeptidyl peptidase IV (DP IV)
AU2003293311A1 (en) * 2002-09-18 2004-04-23 Prosidion Ltd. Secondary binding site of dipeptidyl peptidase iv (dp iv)
ATE462432T1 (de) 2003-05-05 2010-04-15 Probiodrug Ag Glutaminylcyclase-hemmer
KR20120035203A (ko) 2003-05-05 2012-04-13 프로비오드룩 아게 글루타미닐 및 글루타메이트 사이클라제의 이펙터의 용도
WO2005039548A2 (en) * 2003-10-15 2005-05-06 Probiodrug Ag Use of effectors of glutaminyl and glutamate cyclases
US20050171112A1 (en) * 2003-11-03 2005-08-04 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US20100099721A1 (en) * 2003-11-03 2010-04-22 Probiodrug Ag Novel compounds for the treatment of neurological disorders
WO2005075436A2 (en) 2004-02-05 2005-08-18 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
KR100926417B1 (ko) 2007-01-29 2009-11-12 한올제약주식회사 Ｎ,ｎ―디메틸 이미도디카르본이미딕 디아미드의 초산염,그의 제조방법 및 그를 포함하는 약제학적 조성물
US20080188457A1 (en) * 2007-02-02 2008-08-07 Braincells, Inc. Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
US8076377B2 (en) * 2007-09-21 2011-12-13 Hanall Pharmaceutical Company, Ltd. N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
KR101104912B1 (ko) 2008-01-08 2012-01-12 한올바이오파마주식회사 Ｎ,ｎ―디메틸 이미도디카르본이미딕 디아미드의 니코틴산염, 그의 제조방법 및 그를 포함하는 약제학적 조성물
BRPI0822909B8 (pt) * 2008-06-26 2021-05-25 Laboratorios Silanes S A De C V sal de glicinato de metformina para o controle da glicose sanguínea
US20110021634A1 (en) 2009-06-18 2011-01-27 Patel Pranav Dushyant Processes for preparing metformin hydrochloride
WO2011049400A2 (ko) * 2009-10-23 2011-04-28 한올바이오파마주식회사 N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
KR101324283B1 (ko) 2010-04-27 2013-11-01 한올바이오파마주식회사 바이구아나이드 화합물의 신규 염, 그의 제조방법, 그를 포함하는 약제학적 조성물
WO2018060962A2 (en) 2016-09-30 2018-04-05 Laboratorios Silanes S.A. De C.V. Metformin amino acid compounds and methods of using the same
US11185516B2 (en) 2016-09-30 2021-11-30 Laboratorios Silanes S.A. De C.V. Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
CN106986791A (zh) * 2017-05-11 2017-07-28 杜剑平 一种治疗肿瘤的药物化合物及其制备方法和应用
CN107118130A (zh) * 2017-05-11 2017-09-01 杜剑平 一类治疗肿瘤的药物化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179562A (en) * 1961-08-23 1965-04-20 Du Pont Treatment of diabetes with alpha, alpha substituted acetic acid derivatives

Also Published As

Publication number Publication date
DK457475A (enEXAMPLES) 1976-04-12
AT343676B (de) 1978-06-12
DD123322A5 (enEXAMPLES) 1976-12-12
LU73557A1 (enEXAMPLES) 1977-05-24
IL48116A (en) 1979-07-25
IE41807B1 (en) 1980-03-26
AU8497775A (en) 1977-03-24
BR7506595A (pt) 1976-08-17
FI752626A7 (enEXAMPLES) 1976-04-12
US4028402A (en) 1977-06-07
ATA776375A (de) 1977-10-15
JPS51125718A (en) 1976-11-02
FR2287221A1 (fr) 1976-05-07
SU572200A3 (ru) 1977-09-05
PL95259B1 (pl) 1977-10-31
SE7511357L (sv) 1976-04-12
IE41807L (en) 1976-04-11
BE834369A (fr) 1976-04-12
IL48116A0 (en) 1975-11-25
GB1473256A (en) 1977-05-11
DE2542598A1 (de) 1976-04-22
ES441673A1 (es) 1977-04-01
CA1053258A (en) 1979-04-24
AR209457A1 (es) 1977-04-29
PH12279A (en) 1978-12-12
CH602612A5 (enEXAMPLES) 1978-07-31
NL7511890A (nl) 1976-04-13
ZA755861B (en) 1976-08-25
NO753447L (enEXAMPLES) 1976-04-13
CU34371A (es) 1979-06-01
DK140834B (da) 1979-11-26

Similar Documents

Publication Publication Date Title
AU7459474A (enEXAMPLES)
AU495930B2 (enEXAMPLES)
AU485022B2 (enEXAMPLES)
AR199810A1 (enEXAMPLES)
AU7465674A (enEXAMPLES)
AU480501A (enEXAMPLES)
AU482110A (enEXAMPLES)
AU480049A (enEXAMPLES)
AU480069A (enEXAMPLES)
AU480264A (enEXAMPLES)
AU480308A (enEXAMPLES)
BG20639A1 (enEXAMPLES)
BG20475A1 (enEXAMPLES)
AU480902A (enEXAMPLES)
AU480925A (enEXAMPLES)
AU481220A (enEXAMPLES)
AU481597A (enEXAMPLES)
AU481798A (enEXAMPLES)
BE836685A (enEXAMPLES)
AU481934A (enEXAMPLES)
BE833391A (enEXAMPLES)
AU482307A (enEXAMPLES)
AU479765A (enEXAMPLES)
AU490706A (enEXAMPLES)
AU479523A (enEXAMPLES)